Comparison of serum and plasma measurements of Müllerian inhibiting substance

Fertility and Sterility

Volumn 89, Issue 6, 2008, Pages 1836-1837

  Merhi, Zaher O ^a   Messerlian, Geralyn M ^a   Minkoff, Howard ^a   Eklund, Elizabeth E ^a   Macura, Jerzy ^a   Feldman, Joseph ^a   Rodriguez, Carlos ^a   Seifer, David B ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTI-MULLERIAN HORMONE; HUMANS; PLASMA; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 44349179130     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.05.041     Document Type: Article

References (14)

1. Ficicioglu C., Kutlu T., Baglam E., and Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 85 (2006) 592-596
2. Pastor C.L., Vanderhoof V.H., Lim L.C., Calis K.A., Premkumar A., Guerrero N.T., et al. Pilot study investigating the age-related decline in ovarian function of regularly menstruating normal women. Fertil Steril 84 (2005) 1462-1469
3. Seifer D.B., MacLaughlin D.T., Christian B.P., Feng B., and Shelden R.M. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
4. De Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
5. Fanchin R., Taieb J., Lozano D.H., Ducot B., Frydman R., and Bouyer J. High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20 (2005) 923-927
6. Seifer DB, MacLaughlin DT. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. Published online June 7, 2007 [Epub ahead of print].
7. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., and Tapanainen J.S. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20 (2005) 1820-1826
8. Fleming R., Harborne L., MacLaughlin D.T., Ling D., Norman J., Sattar N., et al. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment. Fertil Steril 83 (2005) 130-136
9. Nakhuda G.S., Chu M.C., Wang J.G., Sauer M.V., and Lobo R.A. Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertil Steril 85 (2006) 1541-1543
10. Lundblad R.L. Considerations for the use of blood plasma and serum for proteomic analysis. Internet J Gastroenterol 1 (2005). http://www.ispub.com Last accessed June 19, 2007
11. Ladenson J.H., Tsai L.M.B., Michael J.M., Kessler G., and Joist J.H. Serum versus heparinized plasma for eighteen common chemistry tests. Am J Clin Pathol 62 (1974) 545-552
12. Tremellen K.P., Kolo M., Gilmore A., and Lekamge D.N. Anti-mullerian hormone as a marker of ovarian reserve. Aust NZ J Obstet Gynaecol 45 (2005) 20-24
13. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., Te Velde E.R., and Broekmans F.J. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 91 (2006) 4057-4063
14. Hudson P.L., Dougas I., Donahoe P.K., Cate R.L., Epstein J., Pepinsky R.B., et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70 (1990) 16-22